Lucid Diagnostics reports Q2 EPS (20c), consensus (22c)
PremiumThe FlyLucid Diagnostics reports Q2 EPS (20c), consensus (22c)
2M ago
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
Premium
The Fly
Lucid Diagnostics’ EsoGuard esophageal precancer testing shows efficacy
2M ago
Lucid Diagnostics announces record quarterly EsoGuard test volume
Premium
The Fly
Lucid Diagnostics announces record quarterly EsoGuard test volume
3M ago
Lucid SOS esophageal cell collection device subject to Class II FDA recall
PremiumThe FlyLucid SOS esophageal cell collection device subject to Class II FDA recall
5M ago
Lucid Diagnostics Raises $11.6M Through Preferred Stock Sale
Premium
Company Announcements
Lucid Diagnostics Raises $11.6M Through Preferred Stock Sale
5M ago
Lucid Diagnostics Highlights Promising EsoGuard Study Results
Premium
Company Announcements
Lucid Diagnostics Highlights Promising EsoGuard Study Results
5M ago
Lucid Diagnostics initiated with a Buy at Maxim
PremiumThe FlyLucid Diagnostics initiated with a Buy at Maxim
8M ago
Lucid Diagnostics to provide DNA test to WTC responder and survivor program
Premium
The Fly
Lucid Diagnostics to provide DNA test to WTC responder and survivor program
8M ago
Lucid Diagnostics Issues Stock for PAVmed Compensation
Premium
Company Announcements
Lucid Diagnostics Issues Stock for PAVmed Compensation
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100